Abcellera Biologics Inc
NASDAQ:ABCL
Abcellera Biologics Inc
Cash from Operating Activities
Abcellera Biologics Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Cash from Operating Activities
-$43.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Arch Biopartners Inc
XTSX:ARCH
|
Cash from Operating Activities
-CA$483.9k
|
CAGR 3-Years
39%
|
CAGR 5-Years
25%
|
CAGR 10-Years
-10%
|
|
Replicel Life Sciences Inc
XTSX:RP
|
Cash from Operating Activities
-CA$2m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Innovotech Inc
XTSX:IOT
|
Cash from Operating Activities
-CA$203k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
See Also
What is Abcellera Biologics Inc's Cash from Operating Activities?
Cash from Operating Activities
-43.9m
USD
Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Cash from Operating Activities amounts to -43.9m USD.